Top Markets
Coin of the day
Greenyn Biotechnology Co., Ltd Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltd

6846
Rang in Aktien #25419
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary... Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Aktienkurs
$1.84
Marktkapitalisierung
$49.75M
Veränderung (1 Tag)
0.87%
Veränderung (1 Jahr)
-24.88%
Land
TW
Handel Greenyn Biotechnology Co., Ltd (6846)

Kategorie

P/B-Verhältnis für Greenyn Biotechnology Co., Ltd (6846)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Greenyn Biotechnology Co., Ltd beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Greenyn Biotechnology Co., Ltd von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.7087 -
US